- 1.
Panay N, Anderson RA, Nappi RE et al. Premature ovarian insufficiency: an International Menopause Society White Paper. Climacteric 2020; 23: 426–46. [PubMed][CrossRef]
- 2.
Webber L, Davies M, Anderson R et al. ESHRE Guideline: management of women with premature ovarian insufficiency. Hum Reprod 2016; 31: 926–37. [PubMed][CrossRef]
- 3.
Norsk gynekologisk forening. Veileder i gynekologi (2021). https://www.legeforeningen.no/foreningsledd/fagmed/norsk-gynekologisk-forening/veiledere/veileder-i-gynekologi/ Lest 21.3.2022.
- 4.
Haukvik UK, Dieset I, Bjøro T et al. Treatment-related premature ovarian failure as a long-term complication after Hodgkin's lymphoma. Ann Oncol 2006; 17: 1428–33. [PubMed][CrossRef]
- 5.
Oktem O, Kim SS, Selek U et al. Ovarian and Uterine Functions in Female Survivors of Childhood Cancers. Oncologist 2018; 23: 214–24. [PubMed][CrossRef]
- 6.
Eskenazi S, Bachelot A, Hugon-Rodin J et al. Next Generation Sequencing Should Be Proposed to Every Woman With "Idiopathic" Primary Ovarian Insufficiency. J Endocr Soc 2021; 5: b032. [PubMed][CrossRef]
- 7.
França MM, Mendonca BB. Genetics of Primary Ovarian Insufficiency in the Next-Generation Sequencing Era. J Endocr Soc 2019; 4: bvz037. [PubMed][CrossRef]
- 8.
Kirshenbaum M, Orvieto R. Premature ovarian insufficiency (POI) and autoimmunity-an update appraisal. J Assist Reprod Genet 2019; 36: 2207–15. [PubMed][CrossRef]
- 9.
Grossmann B, Saur S, Rall K et al. Prevalence of autoimmune disease in women with premature ovarian failure. Eur J Contracept Reprod Health Care 2020; 25: 72–5. [PubMed][CrossRef]
- 10.
Kassotis CD, Vandenberg LN, Demeneix BA et al. Endocrine-disrupting chemicals: economic, regulatory, and policy implications. Lancet Diabetes Endocrinol 2020; 8: 719–30. [PubMed][CrossRef]
- 11.
Vabre P, Gatimel N, Moreau J et al. Environmental pollutants, a possible etiology for premature ovarian insufficiency: a narrative review of animal and human data. Environ Health 2017; 16: 37. [PubMed][CrossRef]
- 12.
Lindh-Åstrand L, Hoffmann M, Järvstråt L et al. Hormone therapy might be underutilized in women with early menopause. Hum Reprod 2015; 30: 848–52. [PubMed][CrossRef]
- 13.
Popat VB, Calis KA, Vanderhoof VH et al. Bone mineral density in estrogen-deficient young women. J Clin Endocrinol Metab 2009; 94: 2277–83. [PubMed][CrossRef]
- 14.
Anagnostis P, Siolos P, Gkekas NK et al. Association between age at menopause and fracture risk: a systematic review and meta-analysis. Endocrine 2019; 63: 213–24. [PubMed][CrossRef]
- 15.
Mishra SR, Chung HF, Waller M et al. Duration of estrogen exposure during reproductive years, age at menarche and age at menopause, and risk of cardiovascular disease events, all-cause and cardiovascular mortality: a systematic review and meta-analysis. BJOG 2021; 128: 809–21. [PubMed][CrossRef]
- 16.
Jacobsen BK, Heuch I, Kvåle G. Age at natural menopause and all-cause mortality: a 37-year follow-up of 19,731 Norwegian women. Am J Epidemiol 2003; 157: 923–9. [PubMed][CrossRef]
- 17.
Georgakis MK, Beskou-Kontou T, Theodoridis I et al. Surgical menopause in association with cognitive function and risk of dementia: A systematic review and meta-analysis. Psychoneuroendocrinology 2019; 106: 9–19. [PubMed][CrossRef]
- 18.
Miller VM, Jayachandran M, Barnes JN et al. Risk factors of neurovascular ageing in women. J Neuroendocrinol 2020; 32: e12777. [PubMed][CrossRef]
- 19.
Fraison E, Crawford G, Casper G et al. Pregnancy following diagnosis of premature ovarian insufficiency: a systematic review. Reprod Biomed Online 2019; 39: 467–76. [PubMed][CrossRef]
- 20.
Rosario R, Anderson RA. Novel approaches to fertility restoration in women with premature ovarian insufficiency. Climacteric 2021; 24: 491–7. [PubMed][CrossRef]
- 21.
Li XT, Li PY, Liu Y et al. Health-related quality-of-life among patients with premature ovarian insufficiency: a systematic review and meta-analysis. Qual Life Res 2020; 29: 19–36. [PubMed][CrossRef]
- 22.
Golezar S, Keshavarz Z, Ramezani Tehrani F et al. An exploration of factors affecting the quality of life of women with primary ovarian insufficiency: a qualitative study. BMC Womens Health 2020; 20: 163. [PubMed][CrossRef]
()
Denne artikkelen ble publisert for mer enn 12 måneder siden, og vi har derfor stengt for nye kommentarer.
Meningsløs informasjon uten kvantifisering av effekter
22.07.2022For å unngå feilaktig eller direkte skadelig informasjon om medisin og helse er journalister anbefalt å kvantifisere effekter (1). Det samme rådet gis til forskere (2). Noen enkle historier fortelles nå om og om igjen. En slik er at lavt østrogen gir nedsatt…